Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial

Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the Estimated Study Completion Date, which is now estimated to be February 6, 2025.
    Difference
    0.0%
    Check dated 2024-05-07T21:22:23.000Z thumbnail image
  7. Check
    12 days ago
    Change Detected
    Summary
    The value 03 22 03 21 03 22 03 has recently changed to 05 06 05 02 (Estimated) 05 06 05. This change likely represents an update in the efficacy, safety, and pharmacokinetic profile evaluation of asciminib in combination with imatinib in patients with Chronic Myeloid Leukemia in chronic phase (CML-CP) in a Phase 2 study.
    Difference
    0.6%
    Check dated 2024-05-06T19:14:27.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T23:11:23.000Z thumbnail image

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.